Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 15/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 9/20 | 0.35 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.35 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.34 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29164791 | 1.00 | PIK3CD (0.35) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164788 | 1.00 | PIK3CD (0.35) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164848 | 0.91 | PIK3CD (0.32) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164843 | 0.91 | PIK3CD (0.32) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL30822674 | 0.91 | PIK3CD (0.32) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL30822706 | 0.84 | PIK3CD (0.35) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164749 | 0.84 | PIK3CD (0.35) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164747 | 0.84 | PIK3CD (0.35) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164841 | 0.80 | PIK3CD (0.41) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA | |
| SCHEMBL29164838 | 0.80 | PIK3CD (0.41) | PIK3CDPIK3CBPIK3CGPIK3R1PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117659001-A | Aminopyrimidine derivatives and their use in medicine | 广东东阳光药业股份有限公司 | 2024-03-08 | — | — | CN | disclosed |